Dissociation between the renal effects of angiotensin I and II in sodium-restricted normal subjects
- 1 April 1998
- journal article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 38 (1) , 215-220
Abstract
To determine whether the effects of angiotensin I (AngI) in humans can be explained entirely by its plasmatic conversion to angiotensin II (AngII). Ten healthy male volunteers on a sodium-restricted diet were studied on two separate occasions. during which, in random order, AngI or AngII was infused in increasing doses of 0.3, 1 and 3 pmol x kg-1 x min-1. Mean arterial pressure (MAP), effective renal plasma flow (ERPF), glomerular filtration rate (GER), active plasma renin concentration (APRC), AngII, aldosterone (Aldo) and catecholamines were assessed at baseline, after each dose of AngI or AngII and 30 and 60 min after discontinuation of the AngI/AngII infusion. The rise in plasma AngII was significantly less during AngI infusion as compared to AngII infusion (P < 0.05). Changes in MAP, Aldo and GFR, however, were compatible during both infusions. In the kidney, on the other hand, the decrements in APRC and ERPF during AngII infusion exceeded those during AngI (P < 0.05). After cessation of either infusion. AngII concentrations, MAP, ERPF and Aldo returned to baseline levels within 1 h. Renin, however, was still significantly inhibited at that time (P < 0.05). Catecholamines remained virtually unchanged during all experiments. Our data show that AngI and AngII have similar effects on blood pressure and Aldo, but they differ in their renal effects. The latter may be due to a low renal capacity to convert AngI. The prolonged inhibition of renin release after cessation of the infusions may be caused by reduced renin mRNA expression or by accumulation of AngII in the kidney.Keywords
This publication has 13 references indexed in Scilit:
- Natriuretic Effect of Nitrendipine Is Preceded by Transient Systemic and Renal Hemodynamic EffectsCardiovascular Drugs and Therapy, 1997
- Efficacy of intrarenal ACE-inhibition estimated from the renal response to angiotensin I and II in humansKidney International, 1995
- Two-Site Direct Immunoassay Specific for Active ReninClinical Chemistry, 1992
- Metabolism of angiotensin I by different tissues in the intact animalAmerican Journal of Physiology-Heart and Circulatory Physiology, 1992
- Production of angiotensins I and II at tissue sites in intact pigsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1992
- Angiotensin formation in the isolated rat hindlimbJournal Of Hypertension, 1989
- Inhibition of Captopril-Induced Renin Release by Angiotensin IIJournal of Cardiovascular Pharmacology, 1987
- Disappearance of Angiotensin II and Noradrenaline from the Renal and Femoral Circulations of the DogClinical Science, 1980
- Evaluation of a new commercial radioassay kit for aldosterone using an iodinated tracerClinical Biochemistry, 1979
- Conversion of Angiotensin I into Angiotensin II in the Isolated Perfused Rat KidneyClinical Science, 1973